Etoricoxib - Revision history

Helen: /* Side Effects */

2020-10-14T03:04:29Z

Side Effects

← Older revision		Revision as of 23:04, 13 October 2020
Line 59:		Line 59:
	{\| class = "wikitable"		{\| class = "wikitable"
	!style="text-align: left"\| Common side effects		!style="text-align: left"\| Common side effects
	\|Abdominal pain, nausea, ~~iarrhea~~		\|Abdominal pain, nausea, diarrhea

	\|-		\|-

2020-10-14T03:04:12Z

Side Effects

← Older revision		Revision as of 23:04, 13 October 2020
Line 59:		Line 59:
	{\| class = "wikitable"		{\| class = "wikitable"
	!style="text-align: left"\| Common side effects		!style="text-align: left"\| Common side effects
	\|Abdominal pain		\|Abdominal pain, nausea, iarrhea
	nausea
	~~diarrhea~~

	\|-		\|-
	!style="text-align: left"\| Serious side effects		!style="text-align: left"\| Serious side effects
	\|Heart attacks		\|Heart attacks, strokes, gastrointestinal perforation, gastrointestinal bleeding, kidney failure

	~~Strokes~~

	~~Gastrointestinal~~ perforation

	~~Gastrointestinal~~ bleeding

	~~Kidney~~ failure

	\|}		\|}


	It is generally accepted that COX-2 inhibitor may cause less gastrotoxicity than that seen with the non-selective inhibition of the traditional NSAIDs. However, reports that upper gastrointestinal perforation, ulceration and bleeds have occurred with etoricoxib treatment and should not be used in patients with active gastrointestinal ulceration or bleeding.		It is generally accepted that COX-2 inhibitor may cause less gastrotoxicity than that seen with the non-selective inhibition of the traditional NSAIDs. However, reports that upper gastrointestinal perforation, ulceration and bleeds have occurred with etoricoxib treatment and should not be used in patients with active gastrointestinal ulceration or bleeding.

2020-10-12T07:35:05Z

Side Effects

← Older revision		Revision as of 03:35, 12 October 2020
Line 64:		Line 64:

	\|-		\|-
	\|style="text-align: left"\| Serious side effects		!style="text-align: left"\| Serious side effects
	\|Heart attacks		\|Heart attacks

2020-10-12T07:34:51Z

Side Effects

← Older revision		Revision as of 03:34, 12 October 2020
Line 63:		Line 63:
	diarrhea		diarrhea

			\|-
	\|style="text-align: left"\| Serious side effects		\|style="text-align: left"\| Serious side effects
	\|Heart attacks		\|Heart attacks

	Strokes		Strokes

	Gastrointestinal perforation		Gastrointestinal perforation

	Gastrointestinal bleeding		Gastrointestinal bleeding

	Kidney failure		Kidney failure

2020-10-12T07:34:07Z

Side Effects

← Older revision		Revision as of 03:34, 12 October 2020
Line 57:		Line 57:

	==Side Effects==		==Side Effects==
			{\| class = "wikitable"
			!style="text-align: left"\| Common side effects
			\|Abdominal pain
			nausea
			diarrhea

	~~Common side effects :~~
	*Abdominal pain, nausea and diarrhea.

	Serious side effects :		\|style="text-align: left"\| Serious side effects
	*Heart attacks		\|Heart attacks
	*Strokes		Strokes
	*Gastrointestinal perforation		Gastrointestinal perforation
	*Gastrointestinal bleeding		Gastrointestinal bleeding
	*Kidney failure		Kidney failure
	*Anaphylaxis
			\|}


	It is generally accepted that COX-2 inhibitor may cause less gastrotoxicity than that seen with the non-selective inhibition of the traditional NSAIDs. However, reports that upper gastrointestinal perforation, ulceration and bleeds have occurred with etoricoxib treatment and should not be used in patients with active gastrointestinal ulceration or bleeding.		It is generally accepted that COX-2 inhibitor may cause less gastrotoxicity than that seen with the non-selective inhibition of the traditional NSAIDs. However, reports that upper gastrointestinal perforation, ulceration and bleeds have occurred with etoricoxib treatment and should not be used in patients with active gastrointestinal ulceration or bleeding.

2020-10-12T07:31:10Z

Side Effects

← Older revision		Revision as of 03:31, 12 October 2020
Line 58:		Line 58:
	==Side Effects==		==Side Effects==

	Common side effects ~~include~~:		Common side effects :
	*Abdominal pain, nausea and diarrhea.		*Abdominal pain, nausea and diarrhea.

	Serious side effects ~~may include~~:		Serious side effects :
	*Heart attacks		*Heart attacks
	*Strokes		*Strokes

2020-10-12T07:29:06Z

Dosage

← Older revision		Revision as of 03:29, 12 October 2020
Line 37:		Line 37:
	{\| class = "wikitable"		{\| class = "wikitable"
	! style="text-align: left"\| Osteoarthritis		! style="text-align: left"\| Osteoarthritis
	\| Oral: 30 mg daily once daily, increased to 60 mg once daily if necessary.		\| Oral : 30 mg daily once daily, increased to 60 mg once daily if necessary.
	\|-		\|-
	! style="text-align: left"\| Rheumatoid arthritis and ankylosing spondylitis		! style="text-align: left"\| Rheumatoid arthritis and ankylosing spondylitis
Line 43:		Line 43:
	\|-		\|-
	! style="text-align: left"\| Gouty arthritis		! style="text-align: left"\| Gouty arthritis
	\| Oral: 120 mg once daily.		\| Oral : 120 mg once daily.
	Such higher doses should only be used for acute symptomatic period and for a maximum of 8 days.		Such higher doses should only be used for acute symptomatic period and for a maximum of 8 days.
	\|-		\|-
	! style="text-align: left"\| Postoperative dental pain		! style="text-align: left"\| Postoperative dental pain
	\| Oral: 90 mg once daily for a maximum of 3 days.		\| Oral : 90 mg once daily for a maximum of 3 days.
	\|-		\|-
	! style="text-align: left"\| Administration in hepatic impairment		! style="text-align: left"\| Administration in hepatic impairment

2020-10-12T07:25:53Z

Dosage

← Older revision		Revision as of 03:25, 12 October 2020
Line 50:		Line 50:
	\|-		\|-
	! style="text-align: left"\| Administration in hepatic impairment		! style="text-align: left"\| Administration in hepatic impairment
	\| Mild hepatic impairment: 60 mg once daily		\| Mild hepatic impairment : 60 mg once daily
	Moderate hepatic impairment: 60 mg every other day or 30 mg once daily.		Moderate hepatic impairment : 60 mg every other day or 30 mg once daily.

	''Etoricoxib should not be given to patients with severe hepatic impairment.''		''Etoricoxib should not be given to patients with severe hepatic impairment.''

2020-10-12T07:25:34Z

Dosage

← Older revision		Revision as of 03:25, 12 October 2020
Line 53:		Line 53:
	Moderate hepatic impairment: 60 mg every other day or 30 mg once daily.		Moderate hepatic impairment: 60 mg every other day or 30 mg once daily.

	Etoricoxib should not be given to patients with severe hepatic impairment.		''Etoricoxib should not be given to patients with severe hepatic impairment.''
	\|}		\|}

2020-10-12T07:25:12Z

Dosage

← Older revision		Revision as of 03:25, 12 October 2020
Line 36:		Line 36:
	==Dosage==		==Dosage==
	{\| class = "wikitable"		{\| class = "wikitable"
	! style="text-align: left"\| ~~For osteoarthritis~~		! style="text-align: left"\| Osteoarthritis
	\| Oral: 30 mg daily once daily, increased to 60 mg once daily if necessary.		\| Oral: 30 mg daily once daily, increased to 60 mg once daily if necessary.
	\|-		\|-
	! style="text-align: left"\| ~~For rheumatoid~~ arthritis and ankylosing spondylitis		! style="text-align: left"\| Rheumatoid arthritis and ankylosing spondylitis
	\| Oral: 60 mg once daily, increased to 90 mg once daily if necessary.		\| Oral: 60 mg once daily, increased to 90 mg once daily if necessary.
	\|-		\|-
	! style="text-align: left"\| ~~For gouty~~ arthritis		! style="text-align: left"\| Gouty arthritis
	\| Oral: 120 mg once daily.		\| Oral: 120 mg once daily.
	Such higher doses should only be used for acute symptomatic period and for a maximum of 8 days.		Such higher doses should only be used for acute symptomatic period and for a maximum of 8 days.
	\|-		\|-
	! style="text-align: left"\| ~~For postoperative~~ dental pain		! style="text-align: left"\| Postoperative dental pain
	\| Oral: 90 mg once daily for a maximum of 3 days.		\| Oral: 90 mg once daily for a maximum of 3 days.
	\|-		\|-